Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9902742 Macrocycles as factor XIa inhibitors

Patent 9902742 was granted and assigned to Bristol-Myers Squibb on February, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

99027420

Patent Inventor Names

Donald J. P. Pinto0

William R. Ewing0

Wu Yang0

Yufeng Wang0

James R. Corte0

Leon M. Smith, II0

Paul J. Gilligan0

Tianan Fang0

Date of Patent

February 27, 2018

Patent Application Number

154376050

Date Filed

February 21, 2017

Patent Citations Received

‌

US Patent 11667649 Heteroaromatic macrocyclic ether chemotherapeutic agents

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

The present invention provides compounds of Formula (Ia):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9902742 Macrocycles as factor XIa inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API